Annual CFI
$68.36 M
+$294.00 M+130.29%
31 December 2023
Summary:
IGM Biosciences annual cash flow from investing activities is currently $68.36 million, with the most recent change of +$294.00 million (+130.29%) on 31 December 2023. During the last 3 years, it has risen by +$10.07 million (+17.27%). IGMS annual CFI is now at all-time high.IGMS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$12.99 M
-$11.54 M-47.05%
30 September 2024
Summary:
IGM Biosciences quarterly cash flow from investing activities is currently $12.99 million, with the most recent change of -$11.54 million (-47.05%) on 30 September 2024. Over the past year, it has dropped by -$6.56 million (-33.57%). IGMS quarterly CFI is now -81.40% below its all-time high of $69.82 million, reached on 31 March 2023.IGMS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$31.47 M
-$6.56 M-17.26%
30 September 2024
Summary:
IGM Biosciences TTM cash flow from investing activities is currently $31.47 million, with the most recent change of -$6.56 million (-17.26%) on 30 September 2024. Over the past year, it has dropped by -$32.77 million (-51.01%). IGMS TTM CFI is now -66.18% below its all-time high of $93.04 million, reached on 30 June 2021.IGMS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +130.3% | -33.6% | -51.0% |
| 3 y3 years | +17.3% | +127.6% | -8.7% |
| 5 y5 years | +8774.5% | +122.3% | +152.9% |
IGMS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +130.3% | -81.4% | +107.1% | -54.0% | +112.7% |
| 5 y | 5 years | at high | +130.3% | -81.4% | +107.1% | -66.2% | +112.7% |
| alltime | all time | at high | +130.3% | -81.4% | +107.1% | -66.2% | +112.7% |
IGM Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.99 M(-47.0%) | $31.47 M(-17.3%) |
| June 2024 | - | $24.52 M(+183.5%) | $38.03 M(+429.5%) |
| Mar 2024 | - | $8.65 M(-158.9%) | $7.18 M(-89.5%) |
| Dec 2023 | $68.36 M(-130.3%) | -$14.69 M(-175.2%) | $68.36 M(+6.4%) |
| Sept 2023 | - | $19.55 M(-409.1%) | $64.24 M(+56.9%) |
| June 2023 | - | -$6.33 M(-109.1%) | $40.94 M(-129.9%) |
| Mar 2023 | - | $69.82 M(-471.2%) | -$136.72 M(-39.4%) |
| Dec 2022 | -$225.64 M(-1559.4%) | -$18.81 M(+401.9%) | -$225.64 M(+10.3%) |
| Sept 2022 | - | -$3.75 M(-98.0%) | -$204.59 M(-17.5%) |
| June 2022 | - | -$183.98 M(+863.1%) | -$247.96 M(+473.3%) |
| Mar 2022 | - | -$19.10 M(-952.8%) | -$43.25 M(-379.8%) |
| Dec 2021 | $15.46 M | $2.24 M(-104.8%) | $15.46 M(-55.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$47.11 M(-327.4%) | $34.45 M(-63.0%) |
| June 2021 | - | $20.72 M(-47.7%) | $93.04 M(+34.1%) |
| Mar 2021 | - | $39.61 M(+86.6%) | $69.37 M(+19.0%) |
| Dec 2020 | $58.29 M(-128.7%) | $21.23 M(+84.8%) | $58.29 M(-154.6%) |
| Sept 2020 | - | $11.48 M(-488.9%) | -$106.67 M(-39.6%) |
| June 2020 | - | -$2.95 M(-110.4%) | -$176.51 M(+1.4%) |
| Mar 2020 | - | $28.53 M(-119.8%) | -$173.99 M(-14.4%) |
| Dec 2019 | -$203.24 M(>+9900.0%) | -$143.73 M(+146.3%) | -$203.24 M(+241.5%) |
| Sept 2019 | - | -$58.36 M(>+9900.0%) | -$59.51 M(+5083.9%) |
| June 2019 | - | -$433.00 K(-39.4%) | -$1.15 M(+60.6%) |
| Mar 2019 | - | -$715.00 K | -$715.00 K |
| Dec 2018 | -$788.00 K(+104.7%) | - | - |
| Dec 2017 | -$385.00 K | - | - |
FAQ
- What is IGM Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for IGM Biosciences?
- What is IGM Biosciences annual CFI year-on-year change?
- What is IGM Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for IGM Biosciences?
- What is IGM Biosciences quarterly CFI year-on-year change?
- What is IGM Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for IGM Biosciences?
- What is IGM Biosciences TTM CFI year-on-year change?
What is IGM Biosciences annual cash flow from investing activities?
The current annual CFI of IGMS is $68.36 M
What is the all time high annual CFI for IGM Biosciences?
IGM Biosciences all-time high annual cash flow from investing activities is $68.36 M
What is IGM Biosciences annual CFI year-on-year change?
Over the past year, IGMS annual cash flow from investing activities has changed by +$294.00 M (+130.29%)
What is IGM Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of IGMS is $12.99 M
What is the all time high quarterly CFI for IGM Biosciences?
IGM Biosciences all-time high quarterly cash flow from investing activities is $69.82 M
What is IGM Biosciences quarterly CFI year-on-year change?
Over the past year, IGMS quarterly cash flow from investing activities has changed by -$6.56 M (-33.57%)
What is IGM Biosciences TTM cash flow from investing activities?
The current TTM CFI of IGMS is $31.47 M
What is the all time high TTM CFI for IGM Biosciences?
IGM Biosciences all-time high TTM cash flow from investing activities is $93.04 M
What is IGM Biosciences TTM CFI year-on-year change?
Over the past year, IGMS TTM cash flow from investing activities has changed by -$32.77 M (-51.01%)